Related references
Note: Only part of the references are listed.Prodynorphin-Derived Peptides Are Critical Modulators of Anxiety and Regulate Neurochemistry and Corticosterone
Walter Wittmann et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Chronic stress-induced alterations in amygdala responsiveness and behavior - modulation by trait anxiety and corticotropin-releasing factor systems
Carmen Sandi et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
The dysphoric component of stress is encoded by activation of the dynorphin κ-opioid system
Benjamin B. Land et al.
JOURNAL OF NEUROSCIENCE (2008)
Corticotropin-releasing factor increases mouse ventral tegmental area dopamine neuron firing through a protein kinase C-dependent enhancement of Ih
M. J. Wanat et al.
JOURNAL OF PHYSIOLOGY-LONDON (2008)
Amygdala intercalated neurons are required for expression of fear extinction
Ekaterina Likhtik et al.
NATURE (2008)
Control of hormonal stress reactivity by the endogenous opioid system
Andras Bilkei-Gorzo et al.
PSYCHONEUROENDOCRINOLOGY (2008)
Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system
Van A. Redila et al.
PSYCHOPHARMACOLOGY (2008)
Animal models of anxiety: do I need multiple tests?
Andre Ramos
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
CRF1 receptor activation increases the response of neurons in the basolateral nucleus of the amygdala to afferent stimulation
Annarosa Ugolini
Frontiers in Behavioral Neuroscience (2008)
Activation of basolateral amygdala corticotropin-releasing factor 1 receptors modulates the consolidation of contextual fear
D. T. Hubbard et al.
NEUROSCIENCE (2007)
Anxiolytic-Like effects of κ-opioid receptor antagonists in models of unlearned and learned fear in rats
Allison T. Knoll et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Stress-induced p38 mitogen-activated protein kinase activation mediates κ-opioid-dependent dysphoria
Michael R. Bruchas et al.
JOURNAL OF NEUROSCIENCE (2007)
CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats
Olivier George et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Long-acting κ opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase
Michael R. Bruchas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Reinstatement of cocaine place-conditioning prevented by the peptide kappa-opioid receptor antagonist arodyn
A. N. Carey et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Stressin1-A, a potent corticotropin releasing factor receptor 1 (CRF1)-selective peptide agonist
Jean Rivier et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats
Cindy K. Funk et al.
BIOLOGICAL PSYCHIATRY (2007)
Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats
WA Carlezon et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
The corticotropin-releasing factor receptor-1 pathway mediates the negative affective states of opiate withdrawal
A Contarino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Cocaine experience establishes control of midbrain glutamate and dopamine by corticotropin-releasing factor: A role in stress-induced relapse to drug seeking
B Wang et al.
JOURNAL OF NEUROSCIENCE (2005)
Sensitivity to stress: Dysregulation of CRF pathways and disease development
TL Bale
HORMONES AND BEHAVIOR (2005)
Prolonged kappa opioid receptor phosphorylation mediated by G-protein receptor kinase underlies sustained analgesic tolerance
JP McLaughlin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects
Y Shirayama et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Modulation of anxiety-related behaviors by μ- and κ-opioid receptor agonists depends on the social status of mice
NN Kudryavtseva et al.
PEPTIDES (2004)
Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress
MB Müller et al.
NATURE NEUROSCIENCE (2003)
Antidepressant-like effects of κ-opioid receptor antagonists in the forced swim test in rats
SD Mague et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Dopamine-dependent responses to cocaine depend on corticotropin-releasing factor receptor subtypes
L Lu et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Salvinorin A:: A potent naturally occurring nonnitrogenous κ opioid selective agonist
BL Roth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor1 receptor antagonist.: II.: Characterization in rodent models of stress-related disorders
G Griebel et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor
K Lewis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Methodological and conceptual issues in the use of the elevated plus-maze as a psychological measurement instrument of animal anxiety-like behavior
PM Wall et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2001)
Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression:: the first 20 patients treated
AW Zobel et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2000)
Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress
TL Bale et al.
NATURE GENETICS (2000)
Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2
SC Coste et al.
NATURE GENETICS (2000)
Behavioral effects of central administration of the novel CRF antagonist astressin in rats
MG Spina et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Share Paper
